Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Oil Fuels FTSE Rise As Focus Moves To Fed Minutes

Wed, 06th Apr 2016 16:22

LONDON (Alliance News) - Higher oil prices helped UK stocks rise on Wednesday, with investors now awaiting the publication of the US Federal Reserve minutes for more insight into how divided policymakers are about the timing of future increases in interest rates.

The minutes of the Federal Open Market Committee's March 15-16 meeting are to be released at 1900 BST, after the London close. The market hopes the accounts will shed some light on the outlook for interest rates ahead of the Fed's next meeting at the end of April.

The March meeting revealed Fed members lowered their expectations for US rate increases in 2016 to two from four in the December meeting. This was more dovish than the market expected and sent the dollar lower at the time.

Since the last meeting, several policymakers have said an April rate hike was still on the table, but last week Chair Janet Yellen maintained a dovish tone, suggesting a divide among Fed members on the future path for tightening of US monetary policy. Yellen said she considered it appropriate for the Fed to proceed cautiously in adjusting monetary policy given the risks to the economic outlook.

Analysts at French Bank Societe Generale believe the FOMC minutes will receive less attention than usual because of Yellen's speech last week, but could provide insight into just how divided the committee really is on the "balance of risks" to the US economy.

Ahead of the minutes the pound traded the dollar at USD1.4103 at the close of London equity trading against 1.4133 at the same time on Tuesday. The euro traded the greenback at USD1.1388 versus 1.1370 on Tuesday.

At the London close Wall Street was trading higher. The DJIA was up 0.4%, the S&P 500 was up 0.6%, and the Nasdaq Composite was up 0.8%.

In London, the FTSE 100 closed up 1.2%, or 70.40 points, at 6,161.63. The index was supported by higher oil prices, which rose following comments from Kuwait's OPEC governor and a decline in US crude oil stocks.

On Tuesday, Reuters reported that all signs suggest the meeting of oil producers in Doha on April 17 will deliver an agreement to freeze output, citing Kuwait's OPEC governor Nawal Al-Fuzaia and two other sources.

"There are positive indications an agreement will be reached during this meeting... an initial agreement on freezing production," Al-Fuzaia said.

The comments suggested Iran's aim to increase its production will not scupper a deal aimed at supporting prices and addressing oversupply in the oil market, a big driver of the fall in oil pricing.

Oil prices received a further boost on Wednesday afternoon, when the US Energy Information Administration reported a fall in its crude oil stocks. The US government's official energy statistics body said its crude oil inventory declined by 4.9 million barrels last week. It was the first decline in the EIA's crude oil stocks in eight weeks.

At the London stock market close Brent crude was quoted at USD39.38 a barrel, compared to the USD37.66 a barrel at the London stock market close Tuesday. US benchmark West Texas Intermediate was at USD37.60 a barrel against USD35.66 at the same time on Tuesday.

Elsewhere in commodities, gold was at USD1,221.73 an ounce at the European equities close, versus USD1,228.82 on Tuesday.

The FTSE 250 closed up 0.8%, or 140.52 points, at 16,866.11 and the AIM All-Share ended up 0.5%, or 3.32 points, at 715.44. In Europe, the CAC 40 in Paris rose 0.8%, and the DAX 30 in Frankfurt ended up 0.6%.

On the London Stock Exchange, pharmaceutical companies ended as the best performers in the FTSE 100, with Shire up 4.9%, AstraZeneca, up 3.3%, and GlaxoSmithKline up 1.2%.

Connor Campbell, financial analyst at Spreadex, said UK drugmakers were boosted by the termination of US peer Pfizer's USD160 billion merger with botox maker Allergan.

"The fallout from the failed Pfizer/Allergan merger causing many to speculate that the former might be go shopping again to satisfy its M&A-thirst," Campbell said.

CRH ended up 2.1% after JPMorgan Cazenove lifted its recommendation to Overweight from Neutral. The bank said it believes the Irish building materials company's "attractive" valuation offers an "interesting entry point".

EasyJet closed as the worst FTSE 100 performer, down 3.0%. The low-cost carrier said the number of passengers carried rose in March year-on-year, but its load factor declined following cancellations due to strikes in France.

The number of passengers carried grew by 4.3% in March to 5.7 million from 5.5 million in the same month a year before, the company said. Load factor, however, declined by 1.3 percentage points to 91.3% from 92.6%.

EasyJet said it had 611 flight cancellations in March, with the majority due to air traffic control strikes in France.

Miner and commodities trading house Glencore said it agreed to offload a substantial stake in its agricultural business to a Canadian pension fund in a deal that suggests the company is well and truly on its way to delivering its asset disposal and debt reduction plan in 2016.

Glencore agreed to sell a 40% stake in its Agricultural Products business to Canada Pension Plan Investment Board for USD2.5 billion, with Barclays, Citigroup and Credit Suisse all advising Glencore on the anticipated deal.

The payment for the stake will be made in cash upon closing of the deal, but is still subject to customary working capital adjustments and also needs regulatory approval. Glencore expects the deal to formally close before the end of June.

Glencore closed down 1.7%, making it one of the worst performers in the FTSE 100, but the stock has still increased by more than half to date in 2016.

Telecom Plus ended as the worst performer in the FTSE 250, down 6.1% after Berenberg downgraded it to Hold from Buy. The German bank believes the company will struggle to attract new customers as competitors benefit from lower utility prices whilst it is tied into a long-term contract with npower.

It is another thin economic calendar on Thursday, with the highlight being central banker speeches. The Fed's Yellen is due to speak at 2230 BST, while European Central Bank President Mario Draghi is expected to make a speech in Lisbon.

Also in the calendar is the publication of ECB's monetary policy meeting accounts at 1230 BST, US continuing and initial jobless claims at 1330 BST and US consumer credit at 2000 BST.

The focus in the UK corporate calendar is a trading statement from FTSE 100 food and homewares retailer Marks & Spencer Group.

Elsewhere, there are trading statements from homewares retailer Dunelm Group, specialty chemicals Victrex and European airline Flybe Group. FTSE 250 gold miner Centamin reports first quarter production results, while speciality pharmaceutical company Alliance Pharma and healthcare company PureTech Health both report full-year results.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.